OPXBIO uses its proprietary, leading EDGE™ (Efficiency Directed Genome Engineering) technology to manufacture renewable bio-based chemicals and fuels that are lower cost, higher return and more sustainable than existing petroleum-based products. In addition to DBL Partners, investors include:X/Seed Capital, USRG, Mohr Davidow, Braemar Energy Ventures and Wolfensohn & Co.